Conditions: Carcinoma, Renal Cell
Keywords: metastatic renal cell carcinoma cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 60
Healthy volunteers: no

Brief summary:
The purpose of this study is to learn if PET scanning can predict the degree of tumor shrinkage with the study drug RAD001 in subjects who have advanced renal cancer.

Detailed description:

Arms:
arm 1: All patients were to receive 10mg everolimus (RAD001) daily.

Interventions: intervention 1: RAD001
Intervention descriptions: intervention 1: take 2 tablets of RAD001 once a day by mouth (10 mg per day)

Protocol document: